Generic Weight-Loss Drugs Won’t Come for Years
Fernandez cites Biocon, Cipla, Divi’s Labs and Sun Pharma for plans to launch liraglutide in the U.S. and other markets. They ...
New Jersey Business Magazine4d
Emerge Program Secures Sun Pharma’s Presence in NJ
The NJEDA Board approved tax credits under the Emerge Program to support Sun Pharmaceutical Industries Inc.’s plan to open a ...
Generic drugmaker races to launch versions of blockbuster obesity drugs
Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year ...
Hosted on MSN21d
Mankind Pharma develops oral anti-obesity drug, eyes global breakthrough
Sun Pharmaceutical Industries is developing ... entered the space in 2024 with the launch of Lirafit, a biosimilar of liraglutide. Meanwhile, Biocon has received authorisation to market a generic ...